Impact of Insurance and Risk Factors on DBS Outcomes
Objective: Assess the effect of insurance type on deep brain stimulation (DBS) outcomes, and identify risk factors for progression to assisted ambulation and dependency (home…Tracking The Role Of The Subthalamo-Temporal Network In Speech: A Deep Brain Stimulation-Electroencephalography Study
Objective: To identify deep brain stimulation (DBS)-related disruption of the subthalamic nucleus (STN)–temporal network as a possible source of STN-DBS induced dysarthria. Background: STN-DBS often…Evoked Resonant Neural Activity localises STN DBS programs more ventrally than clinician and imaging-guided methods in Parkinson’s disease
Objective: To compare 3 methods of localising STN DBS programs for PD; 1) clinical standard of care (SOC), 2) imaging-based programming (IBP), 3) novel algorithm…Weight loss post deep brain stimulation to bilateral subthalamic nuclei in a Parkinson’s disease with PARKIN mutation – A Harbinger sign of malignancy
Objective: We present a challenging case of genetic PD who presented with progressive weight loss and constipation despite post-DBS and was found to have malignancy.…Risk Factors and Outcome of Dopamine Dysregulation Syndrome in a large Chinese Parkinson’s Disease Cohort
Objective: We conducted a large-sample study to investigate the clinical characteristics and related risk factors of DDS in China. In addition, we further followed up…Characterization of autonomic dysfunction in prodromal and early stages of Parkinson’s Disease
Objective: To evaluate cardiovascular autonomic dysfunction across prodromal stages of synucleinopathies (Pure Autonomic Failure-PAF); isolated REM Sleep Behavior Disorder-iRBD) and early stages of Parkinson’s disease…Vagus nerve ultrasound and its association with non-motor symptoms in parkinson’s disease
Objective: To evaluate the vagus nerve (VN) diameter with ultrasonography in Parkinson’s disease (PD) patients compared to healthy controls and explore its relationship with non-motor…Proteomic analysis identifies GGA1, SCP2, and RABEPK as risk protein of multiple system atrophy
Objective: Investigating proteomic changes preceding MSA onset to provide critical insights into disease biology, uncover novel biomarkers for early detection, and identify potential therapeutic targets.…Blood levels of Cathepsin B are linked to a reduced risk of Parkinson’s disease
Objective: To assess the causal impact of plasma Cathepsin B (CTSB) levels on Parkinson’s disease (PD) risk. Background: Cathepsin B is a crucial lysosomal cysteine…Automatic Intelligibility Rating in Parkinson’s Disease: A Multilingual Approach
Objective: To investigate the validity and robustness of an automatically generated intelligibility score in Parkinson’s disease (PD) across multiple languages. Background: 90% of people with…
- « Previous Page
- 1
- …
- 19
- 20
- 21
- 22
- 23
- …
- 181
- Next Page »